Risk Screening & Primary Prevention of Elder Abuse in People Living With Dementia (NCT07429591) | Clinical Trial Compass
SuspendedNot Applicable
Risk Screening & Primary Prevention of Elder Abuse in People Living With Dementia
Stopped: Study paused per IRB request.
United States1,000 participantsStarted 2026-05-01
Plain-language summary
The goal of this clinical trial is to test a risk assessment screening and intervention for caregivers of people with dementia. The main questions it aims to answer are:
1. What are the harms and benefits of administering the elder abuse risk assessment screening?
2. What are the harms and benefits of administering the caregiver intervention?
Researchers will compare participants who receive the screening and caregiver intervention to a group who does not receive the caregiver intervention and a group who receives neither the screening or the caregiver intervention to answer these questions.
Participants will:
* Complete two surveys, three months apart
* Complete a 5-item screening tool, if assigned to one of the screening groups
* Complete a 3-session caregiver intervention, if assigned to that group
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 years old or older
* Speak English or Spanish
* Caregiver for a person with Alzheimer's Disease or another type of dementia
* Provide substantial care for this person, defined as assisting with at least one activity of daily living or two instrumental activities of daily living
* See this person at least twice a week
* Have access to the internet
Exclusion Criteria:
* Under 18 years old
* Speak language besides English or Spanish
* Caregiver for person who does not have dementia
* Do not provide substantial care for this person
* Primary relationship between caregiver and person with dementia is that of a professional paid caregiver
* Enrolled in another caregiver study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is currently listed as suspended — can you find out why it was suspended and whether there's any plan for it to resume, so we know if it's even worth continuing to monitor?
2Since this study focuses on caregivers of people with Alzheimer's or memory problems rather than the person with dementia directly, does my situation fit what they're looking for, and what would participation actually involve for me as a caregiver?
3The trial is measuring caregiver depression, anxiety, burden, and stress related to behavioral symptoms — are there existing programs or resources you'd recommend right now that address those same concerns while this trial is on hold?
4Because this trial is listed as Phase NA, meaning it may be more of a screening or prevention program than a drug study, can you explain what kind of intervention or support it would actually provide, and whether there are any risks I should be aware of?
5Given that this trial is specifically focused on preventing elder abuse, is there something about our current caregiving situation that makes you think this kind of risk screening would be especially relevant for us to pursue?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Caregiver Depression Symptoms
Timeframe: Enrollment to three months
2
Caregiver Anxiety Symptoms
Timeframe: Enrollment to three months
3
Caregiver Burden
Timeframe: Enrollment to three months
4
Caregiver Stress About Care Receiver Behavioral Symptoms